Agency: The Emmerson Collective
The Emerson Collective (EC) is proud to announce a new research award program in cancer research in partnership with Duke University. The Duke | EC Cancer Research Fund is requesting individual or team proposals for research projects related, but not limited to, immunotherapy, metabolic therapies, early detection advancements, ‘high risk/high reward’ initiatives and/or -omic approaches to cancer and drug development. Positive criteria include the potential of a project to significantly impact our understanding of and/or approaches to the prevention, diagnosis, or treatment of cancer.
Amount: Gift awards range from $50,000 up to $200,000 for up to 2 years for both direct and indirect costs. You may apply for additional funding for the same projects on subsequent RFP rounds, though new projects will be prioritized. This fund does not support incremental research.
Application Deadline: December 3, 2018
Start Date: March 8, 2019
Eligibility: This RFP is open to all cancer researchers at Duke. Applicants are limited to Duke faculty. Faculty may submit multiple proposals as PI or Co-PI.
A team of Duke | EC Cancer Research Fund employees and associates will evaluate the applicant pool. Applicants will be evaluated on the following positive criteria:
- The audacity and innovation of the research proposal. Incremental research will not be funded.
- The potential of the proposed research to affect multiple cancer types
- The potential to translate said research into further experiments, and clinical trials
- The applicant’s lack of resources to pursue the proposed research
- Compliance with a two-year maximum timeframe for research
The applicant’s prior experimental track record will not be the principal determining factor in evaluation. Finalists may also be interviewed prior to a funding decision.
For more information: https://olv.duke.edu/event/rfp-duke-emerson-cancer/
If you Have questions about this funding opportunity, Contact Erin Carr